{"product_id":"global-nuclear-medicine-market-growth-status-and-outlook-2023-2029","title":"Global Nuclear Medicine Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Nuclear Medicine Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eNuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Nuclear Medicine Industry Forecast” looks at past sales and reviews total world Nuclear Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine sales for 2023 through 2029. With Nuclear Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Nuclear Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Medicine market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine.\u003c\/p\u003e\n\n\u003cp\u003eThe global Nuclear Medicine market size is projected to grow from US$ 6054.6 million in 2022 to US$ 10160 million in 2029; it is expected to grow at a CAGR of 7.7% from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eNorth America is the largest consumption area, with a consumption market share nearly 50%. Following North America, Europe is the second place consumption region with the consumption market share of about 25%.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Nuclear Medicine key manufacturers include GE Healthcare, Bracco Imaging, etc. The global top 2 manufacturers account for over 30 percent of total share.\u003c\/p\u003e\n\n\u003cp\u003eThe classification of Nuclear Medicine includes Tc-99, I-123\/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 is about 50%.\u003c\/p\u003e\n\n\u003cp\u003eNuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003c\/p\u003e\n\n \u003cp\u003eTc-99\u003c\/p\u003e\n\n \u003cp\u003eI-123\/131\u003c\/p\u003e\n\n \u003cp\u003eIn-111\u003c\/p\u003e\n\n \u003cp\u003eXe-133\u003c\/p\u003e\n\n \u003cp\u003eTh-201\u003c\/p\u003e\n\n \u003cp\u003eGa-67\u003c\/p\u003e\n\n \u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003c\/p\u003e\n\n \u003cp\u003eDiagnostic\u003c\/p\u003e\n\n \u003cp\u003eTherapeutic\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003c\/p\u003e\n\n \u003cp\u003eAmericas\u003c\/p\u003e\n\n \u003cp\u003eUnited States\u003c\/p\u003e\n\n \u003cp\u003eCanada\u003c\/p\u003e\n\n \u003cp\u003eMexico\u003c\/p\u003e\n\n \u003cp\u003eBrazil\u003c\/p\u003e\n\n \u003cp\u003eAPAC\u003c\/p\u003e\n\n \u003cp\u003eChina\u003c\/p\u003e\n\n \u003cp\u003eJapan\u003c\/p\u003e\n\n \u003cp\u003eKorea\u003c\/p\u003e\n\n \u003cp\u003eSoutheast Asia\u003c\/p\u003e\n\n \u003cp\u003eIndia\u003c\/p\u003e\n\n \u003cp\u003eAustralia\u003c\/p\u003e\n\n \u003cp\u003eEurope\u003c\/p\u003e\n\n \u003cp\u003eGermany\u003c\/p\u003e\n\n \u003cp\u003eFrance\u003c\/p\u003e\n\n \u003cp\u003eUK\u003c\/p\u003e\n\n \u003cp\u003eItaly\u003c\/p\u003e\n\n \u003cp\u003eRussia\u003c\/p\u003e\n\n \u003cp\u003eMiddle East \u0026amp; Africa\u003c\/p\u003e\n\n \u003cp\u003eEgypt\u003c\/p\u003e\n\n \u003cp\u003eSouth Africa\u003c\/p\u003e\n\n \u003cp\u003eIsrael\u003c\/p\u003e\n\n \u003cp\u003eTurkey\u003c\/p\u003e\n\n \u003cp\u003eGCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003c\/p\u003e\n\n \u003cp\u003eGE Healthcare\u003c\/p\u003e\n\n \u003cp\u003eBracco Imaging\u003c\/p\u003e\n\n \u003cp\u003eMallinckrodt\u003c\/p\u003e\n\n \u003cp\u003eLantheus Medical Imaging\u003c\/p\u003e\n\n \u003cp\u003eBayer\u003c\/p\u003e\n\n \u003cp\u003eTriad Isotopes\u003c\/p\u003e\n\n \u003cp\u003eNordion\u003c\/p\u003e\n\n \u003cp\u003eJubilant Pharma\u003c\/p\u003e\n\n \u003cp\u003eEli Lilly\u003c\/p\u003e\n\n \u003cp\u003eSIEMENS\u003c\/p\u003e\n\n \u003cp\u003eChina Isotope \u0026amp; Radiation\u003c\/p\u003e\n\n \u003cp\u003eDongcheng\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 103 Pages \/ MCW16234411","offer_id":47650946089266,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-nuclear-medicine-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}